Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Royalty Pharma Plc Cl A (RPRX)

52.82   1.32 (2.56%) 01-27 03:27
Open: 51.56 Pre. Close: 51.5
High: 53.15 Low: 51.53
Volume: 2,477,491 Market Cap: 33,025M
Royalty Pharma plc operates in the biopharmaceutical industry. The company operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry. It is involved in the identification, evaluation, and acquisition of royalties and royalty-related assets on various biopharmaceutical therapies. The company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio includes royalties on approximately 45 commercial products and three development-stage product candidates. The company has royalties on various therapeutic areas and drug classes, including Neulasta, Neupogen, Rituxan, Imbruvica, Trodelvy, Tazverik, and Xtandi in oncology; Lyrica in neuropathic pain; Biktarvy, Genvoya, Prezista, Symtuza, Truvada, and Atripla in HIV; Humira, Remicade, and Cimzia TNF inhibitors; Kalydeco, Orkambi, Symdeko, and Trikafta in cystic fibrosis; Tecfidera and Tysabri in multiple sclerosis; Emgality, Nurtec ODT (rimegepant), and vazegepant in migraine; and others. Royalty Pharma plc was founded in 1996 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 53.155 - 53.34 53.34 - 53.51
Low: 50.999 - 51.237 51.237 - 51.454
Close: 52.44 - 52.774 52.774 - 53.08

Technical analysis

as of: 2021-01-26 4:48:26 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 62.17     One year: 72.62
Support: Support1: 47.15    Support2: 43.39
Resistance: Resistance1: 53.23    Resistance2: 62.17
Pivot: 50.63
Moving Average: MA(5): 51.25     MA(20): 50.23
MA(100): 43.34     MA(250):
MACD: MACD(12,26): 1.65     Signal(9): 1.71
Stochastic oscillator: %K(14,3): 80.30     %D(3): 71.17
RSI: RSI(14): 65.51
52-week: High: 56.50  Low: 34.80  Change(%): 18.7
Average Vol(K): 3-Month: 274656  10-Days: 295968

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
RPRX has closed below upper band by 7.3%. Bollinger Bands are 14.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 22 Jan 2021
Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021 - Yahoo Finance

Sun, 10 Jan 2021
Royalty Pharma Ramps Up Dividend By 13% - Nasdaq

Fri, 08 Jan 2021
Royalty Pharma Announces 13% Dividend Increase -

Fri, 08 Jan 2021
Royalty Pharma raises dividend by 13% to $0.17 per share - Seeking Alpha

Fri, 08 Jan 2021
How Does Royalty Pharma plc (RPRX) Stock Rank on Wall Street? - InvestorsObserver

Thu, 07 Jan 2021
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12 - Yahoo Finance

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 366
Shares Float (M) 288
% Held by Insiders 17.50
% Held by Institutions 44.42
Shares Short (K) 13,300
Shares Short P. Month (K) 10,610

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin 110.79
Operating Margin 130.16
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 16.0
Gross Profit (p.s.) 7.734
Sales Per Share 5.493
EBITDA (p.s.) 7.215
Qtrly Earnings Growth -28.90
Operating Cash Flow (M) 1,950
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 9.61
Price to Cash Flow 9.91

Stock Dividends

Forward Dividend 0.680
Dividend Yield
Dividend Pay Date 2021-03-14
Ex-Dividend Date 2020-11-18
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.